Novel CSF and plasma biomarkers such as oxylipins (oxidized lipid mediators), GPX4 fragments, and 8‐iso‐prostaglandin F2α have been identified as indicators of ferroptosis activity and oxidative lipid damage in stroke patients. The gene discussed is GPX4; the disease is stroke disorder.